Skip to main content

Table 1 The pathological data of the collected cases

From: Immunohistochemical expression of CD155 in invasive female breast carcinoma and its correlation with tumor infiltrating natural killer cells

Parameter

Number [%]

Histological type

 

IDC-NST

65 [83.3]

ILC

7 [9]

Mixed duct and lobular

3 [3.8]

Mucinous carcinoma

2 [2.6]

Tubulo-cribriform carcinoma

1 [1.3]

Histological grade

 

Low

48 [61.5]

High

30 [38.5]

T stage

 

Early (T1and T2)

68 [87.2]

Advanced (T3 and T4)

10 [12.8]

Lymph node metastasis

 

Negative

36 [46.2]

Positive

42 [53.8]

Anatomic stage

 

Early [I and II]

58 [74.4]

Advanced [III and IV]

20 [25.6]

Prognostic stage

 

Early [I and II]

41 [59.4]

Advanced [III and IV]

28 [40.6]

ER

 

Positive

66 [84.6]

Negative

12 [15.4]

PR

 

Positive

57 [73.1]

Negative

21 [26.9]

HER2

 

Positive

14 [17.9]

Negative

64 [82.1]

Ki-67 index

 

Low

33 [42.3]

High

45 [57.7]

BC Subtypes

 

Luminal A like

22 [28.2]

Luminal B like-HER2 negative

34 [43.6]

Luminal B like-HER2 positive

10 [12.8]

HER2 positive-non luminal

4 [5.1]

Triple negative

8 [10.3]

LVI

 

Positive

40 [51.3]

Negative

38 [48.7]

Stromal TILs

 

Low

59 [75.6]

High

19 [24.4]

  1. IDC-NST Invasive duct carcinoma of no special type; ILC Invasive lobular carcinoma